Evidence map›Paper›PMID 25883138›Full record

ReviewNucleic acids research2015

The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities.

Anna Kurzynska-Kokorniak, Natalia Koralewska, Maria Pokornowska, Anna Urbanowicz, Aleksander Tworak, Agnieszka Mickiewicz, Marek Figlerowicz

Open access · goldAbstract readReview
In one paragraph

Review in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Dicer and microRNA-155 dysregulation in multiple sclerosis: biomarkers for disease progression and treatment response.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna Kurzynska-KokorniakInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Natalia KoralewskaInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Maria PokornowskaInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Anna UrbanowiczInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Aleksander TworakInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Agnieszka MickiewiczInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland.
Marek FiglerowiczInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan 61-704, Poland Institute of Computing Science, Poznan University of Technology, Poznan 60-965, Poland marekf@ibch.poznan.pl.
Institute of Bioorganic Chemistry, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is increasing evidence indicating that the production of small regulatory RNAs is not the only process in which ribonuclease Dicer can participate. For example, it has been demonstrated that this enzyme is also involved in chromatin structure remodelling, inflammation and apoptotic DNA degradation. Moreover, it has become increasingly clear that cellular transcript and protein levels of Dicer must be strictly controlled because even small changes in their accumulation can initiate various pathological processes, including carcinogenesis. Accordingly, in recent years, a number of studies have been performed to identify the factors regulating Dicer gene expression and protein activity. As a result, a large amount of complex and often contradictory data has been generated. None of these data have been subjected to an exhaustive review or critical discussion. This review attempts to fill this gap by summarizing the current knowledge of factors that regulate Dicer gene transcription, primary transcript processing, mRNA translation and enzyme activity. Because of the high complexity of this topic, this review mainly concentrates on human Dicer. This review also focuses on an additional regulatory layer of Dicer activity involving the interactions of protein and RNA factors with Dicer substrates.

Indexed as

DEAD-box RNA HelicasesGene Expression Regulation, EnzymologicHumansNeoplasmsRibonuclease IIIDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease III

Identifiers

PMID25883138
PMCPMC4482082
OpenAlexW1998236755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.